The economic value of knowing BRCA status : BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer.
Mok OhAli McBrideSandipan BhattacharjeeMarion SlackJoanne JeterIvo AbrahamPublished in: Expert review of pharmacoeconomics & outcomes research (2023)
status of all US ROC patients provides short-term and long-term evidence for optimizing treatment.